Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Aug;24(2):163–167. doi: 10.1128/aac.24.2.163

Comparison of cefadroxil and cephalexin in the treatment of community-acquired pneumonia.

M J Blaser, B D Klaus, J A Jacobson, E Kasworm, F M LaForce
PMCID: PMC185131  PMID: 6605713

Abstract

Thirty-four patients with community-acquired acute pneumonias were treated in a prospective, randomized trial with either cefadroxil, 500 mg twice daily, or cephalexin, 250 mg four times daily. In both groups of patients, the presence of chronic illnesses predisposing to pneumonia was common. Streptococcus pneumoniae was isolated from 65% of the initial sputum specimens, and most illnesses were of mild to moderate severity. All 19 cases treated with cefadroxil and all 15 cases treated with cephalexin were clinically cured, and adverse reactions to the medications were minimal. The success of these regimens suggests that outpatient use of oral cephalosporin therapy may be an appropriate treatment of patients with mild or moderate community-acquired pneumonia.

Full text

PDF
163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTRIAN R., GOLD J. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med. 1964 May;60:759–776. doi: 10.7326/0003-4819-60-5-759. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Boerner D. F., Zwadyk P. The value of the sputum gram's stain in community-acquired pneumonia. JAMA. 1982 Feb 5;247(5):642–645. [PubMed] [Google Scholar]
  4. Dorff G. J., Rytel M. W., Farmer S. G., Scanlon G. Etiologies and characteristic features of pneumonias in a municipal hospital. Am J Med Sci. 1973 Nov;266(5):349–358. doi: 10.1097/00000441-197311000-00002. [DOI] [PubMed] [Google Scholar]
  5. Finland M. Pneumonia and pneumococcal infections, with special reference to pneumococcal pneumonia. The 1979 J. Burns Amberson lecture. Am Rev Respir Dis. 1979 Sep;120(3):481–502. doi: 10.1164/arrd.1979.120.3.481. [DOI] [PubMed] [Google Scholar]
  6. Ginsburg C. M. Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children. J Antimicrob Chemother. 1982 Sep;10 (Suppl B):27–31. doi: 10.1093/jac/10.suppl_b.27. [DOI] [PubMed] [Google Scholar]
  7. La Rosa F., Ripa S., Prenna M., Ghezzi A., Pfeffer M. Pharmacokinetics of cefadroxil after oral administration in humans. Antimicrob Agents Chemother. 1982 Feb;21(2):320–322. doi: 10.1128/aac.21.2.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Leitner F., McGregor M. C., Pursiano T. A. Comparative antibacterial spectrum of cefadroxil. J Antimicrob Chemother. 1982 Sep;10 (Suppl B):1–9. doi: 10.1093/jac/10.suppl_b.1. [DOI] [PubMed] [Google Scholar]
  9. Macfarlane J. T., Finch R. G., Ward M. J., Macrae A. D. Hospital study of adult community-acquired pneumonia. Lancet. 1982 Jul 31;2(8292):255–258. doi: 10.1016/s0140-6736(82)90334-8. [DOI] [PubMed] [Google Scholar]
  10. Mercado F. F., Santella P. J., Fernandez C. A. Clinical experience with cefadroxil in upper and lower respiratory tract infections. J Int Med Res. 1978;6(4):271–279. doi: 10.1177/030006057800600404. [DOI] [PubMed] [Google Scholar]
  11. Murray B. E., Moellering R. C., Jr Antimicrobial agents in pulmonary infections. Med Clin North Am. 1980 May;64(3):319–342. doi: 10.1016/s0025-7125(16)31596-6. [DOI] [PubMed] [Google Scholar]
  12. Quintiliani R., French M., Nightingale C. H. First and second generation cephalosporins. Med Clin North Am. 1982 Jan;66(1):183–197. doi: 10.1016/s0025-7125(16)31452-3. [DOI] [PubMed] [Google Scholar]
  13. Solberg C. O., Schreiner A., Kalager T., Digranes A. Therapy of infections with oral cephalexin. Chemotherapy. 1974;20(5):315–320. doi: 10.1159/000221820. [DOI] [PubMed] [Google Scholar]
  14. Sullivan R. J., Jr, Dowdle W. R., Marine W. M., Hierholzer J. C. Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med. 1972 Jun;129(6):935–942. [PubMed] [Google Scholar]
  15. Weingarten C. Randomized, comparative study of oral cefadroxil and cephalexin in lower respiratory infections in adults. J Antimicrob Chemother. 1982 Sep;10 (Suppl B):109–113. doi: 10.1093/jac/10.suppl_b.109. [DOI] [PubMed] [Google Scholar]
  16. White R. J., Blainey A. D., Harrison K. J., Clarke S. K. Causes of pneumonia presenting to a district general hospital. Thorax. 1981 Aug;36(8):566–570. doi: 10.1136/thx.36.8.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Willems J. S., Sanders C. R., Riddiough M. A., Bell J. C. Cost effectiveness of vaccination against pneumococcal pneumonia. N Engl J Med. 1980 Sep 4;303(10):553–559. doi: 10.1056/NEJM198009043031004. [DOI] [PubMed] [Google Scholar]
  18. Yu V. L., Kroboth F. J., Shonnard J., Brown A., McDearman S., Magnussen M. Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med. 1982 Sep;73(3):357–361. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES